Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2001 | 2 |
2003 | 1 |
2005 | 1 |
2006 | 1 |
2008 | 1 |
2009 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
Multi-peptide vaccines vialed as peptide mixtures can be stable reagents for use in peptide-based immune therapies.
Vaccine. 2009 Mar 10;27(11):1764-70. doi: 10.1016/j.vaccine.2009.01.018. Epub 2009 Feb 8.
Vaccine. 2009.
PMID: 19185050
Free PMC article.
Evaluation of the sentinel immunized node for immune monitoring of cancer vaccines.
Slingluff CL Jr, Yamshchikov GV, Hogan KT, Hibbitts SC, Petroni GR, Bissonette EA, Patterson JW, Neese PY, Grosh WW, Chianese-Bullock KA, Czarkowski A, Rehm PK, Parekh J.
Slingluff CL Jr, et al.
Ann Surg Oncol. 2008 Dec;15(12):3538-49. doi: 10.1245/s10434-008-0046-4. Epub 2008 Oct 16.
Ann Surg Oncol. 2008.
PMID: 18923873
Free PMC article.
Item in Clipboard
Immunity to melanoma antigens: from self-tolerance to immunotherapy.
Slingluff CL Jr, Chianese-Bullock KA, Bullock TN, Grosh WW, Mullins DW, Nichols L, Olson W, Petroni G, Smolkin M, Engelhard VH.
Slingluff CL Jr, et al.
Adv Immunol. 2006;90:243-95. doi: 10.1016/S0065-2776(06)90007-8.
Adv Immunol. 2006.
PMID: 16730266
Review.
Item in Clipboard
Autoimmune toxicities associated with the administration of antitumor vaccines and low-dose interleukin-2.
Chianese-Bullock KA, Woodson EM, Tao H, Boerner SA, Smolkin M, Grosh WW, Neese PY, Merrill P, Petroni GR, Slingluff CL Jr.
Chianese-Bullock KA, et al.
J Immunother. 2005 Jul-Aug;28(4):412-9. doi: 10.1097/01.cji.0000171314.00924.2b.
J Immunother. 2005.
PMID: 16000961
Clinical Trial.
Item in Clipboard
Clinical and immunologic results of a randomized phase II trial of vaccination using four melanoma peptides either administered in granulocyte-macrophage colony-stimulating factor in adjuvant or pulsed on dendritic cells.
Slingluff CL Jr, Petroni GR, Yamshchikov GV, Barnd DL, Eastham S, Galavotti H, Patterson JW, Deacon DH, Hibbitts S, Teates D, Neese PY, Grosh WW, Chianese-Bullock KA, Woodson EM, Wiernasz CJ, Merrill P, Gibson J, Ross M, Engelhard VH.
Slingluff CL Jr, et al.
J Clin Oncol. 2003 Nov 1;21(21):4016-26. doi: 10.1200/JCO.2003.10.005.
J Clin Oncol. 2003.
PMID: 14581425
Clinical Trial.
Item in Clipboard
Evaluation of peptide vaccine immunogenicity in draining lymph nodes and peripheral blood of melanoma patients.
Yamshchikov GV, Barnd DL, Eastham S, Galavotti H, Patterson JW, Deacon DH, Teates D, Neese P, Grosh WW, Petroni G, Engelhard VH, Slingluff CL Jr.
Yamshchikov GV, et al.
Int J Cancer. 2001 Jun 1;92(5):703-11. doi: 10.1002/1097-0215(20010601)92:5<703::aid-ijc1250>3.0.co;2-5.
Int J Cancer. 2001.
PMID: 11340576
Free article.
Item in Clipboard
Analysis of a natural immune response against tumor antigens in a melanoma survivor: lessons applicable to clinical trial evaluations.
Yamshchikov G, Thompson L, Ross WG, Galavotti H, Aquila W, Deacon D, Caldwell J, Patterson JW, Hunt DF, Slingluff CL Jr.
Yamshchikov G, et al.
Clin Cancer Res. 2001 Mar;7(3 Suppl):909s-916s.
Clin Cancer Res. 2001.
PMID: 11300491
Item in Clipboard
Cite
Cite